Drug development, the processes by which a chemical compound becomes a "drug" and is approved for sale by the FDA and European and Asian regulators, is not for the faint-of-heart or the shortsighted. Designing and monitoring studies, obtaining and analyzing scientific data, and reconciling clinical results against the ethical constraints and regulatory guidelines of government agencies, requires a complex interaction of in-house specialists and academic and commercial consultants worldwide. Scientific, technical, and ...
Read More
Drug development, the processes by which a chemical compound becomes a "drug" and is approved for sale by the FDA and European and Asian regulators, is not for the faint-of-heart or the shortsighted. Designing and monitoring studies, obtaining and analyzing scientific data, and reconciling clinical results against the ethical constraints and regulatory guidelines of government agencies, requires a complex interaction of in-house specialists and academic and commercial consultants worldwide. Scientific, technical, and tactical considerations play out in an environment where a balance must be struck between the often-competing interests of the corporation, its investors, government regulators, and the safety and well being of intended patients. All the while, dwindling patent protections impose an ever-contracting timeframe for success. Written to be accessible to a wide audience, NEW DRUGS provides a thorough, succinct, and practical understanding of these drug-development processes. If you're involved in the pharmaceutical industry, NEW DRUGS will provide scientific and management tools to increase the likelihood of regulatory approval at each phase of your compound's development. If you're a patient or consumer, NEW DRUGS will enable you to intelligently discuss medications with your health-care provider and empower you to make informed decisions at the pharmacy. If your portfolio, rather than your health, makes you an interested observer of the fortunes of this critical sector of the US economy, NEW DRUGS will help you to decode press releases and annual reports, so that you can recognize and invest in well-run companies with promising products.
Read Less
Add this copy of New Drugs: an Insider's Guide to the Fda's New Drug to cart. $10.81, fair condition, Sold by ThriftBooks-Reno rated 5.0 out of 5 stars, ships from Reno, NV, UNITED STATES, published 2009 by Booksurge Publishing.
Add this copy of New Drugs: an Insider's Guide to the Fda's New Drug to cart. $12.83, fair condition, Sold by BooksRun rated 5.0 out of 5 stars, ships from Philadelphia, PA, UNITED STATES, published 2009 by PSPG Publishing.
Add this copy of New Drugs: an Insider's Guide to the Fda's New Drug to cart. $13.27, good condition, Sold by 2nd Life Books rated 4.0 out of 5 stars, ships from Burlington, NJ, UNITED STATES, published 2009 by PSPG Publishing.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Used book in good condition. May have some wear to binding spine cover and pages. Some light highlighting markings writing may be present. May have some stickers and or sticker residue present. May be Ex-lib. copy. May NOT include discs or access code or other supplemental material. We ship Monday-Saturday and respond to inquiries within 24 hours.
Add this copy of New Drugs: an Insider's Guide to the Fda's New Drug to cart. $14.23, very good condition, Sold by AmazingBooksPGH rated 5.0 out of 5 stars, ships from Pittsburgh, PA, UNITED STATES, published 2009 by PSPG Publishing.
Add this copy of New Drugs: An Insider's Guide to the FDA's New Drug to cart. $29.09, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2009 by Booksurge Publishing.
Add this copy of New Drugs: an Insider's Guide to the Fda's New Drug to cart. $30.71, new condition, Sold by Just one more Chapter rated 3.0 out of 5 stars, ships from Miramar, FL, UNITED STATES, published 2009 by PSPG Publishing.
Add this copy of New Drugs: an Insider's Guide to the Fda's New Drug to cart. $38.76, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Santa Clarita, CA, UNITED STATES, published 2009 by PSPG Publishing.
Add this copy of New Drugs: an Insider's Guide to the Fda's New Drug to cart. $71.51, new condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Santa Clarita, CA, UNITED STATES, published 2009 by PSPG Publishing.
